Cargando…

Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care

BACKGROUND: Healthcare-associated infections (HCAI) are a worldwide threat in intensive care units particularly in the pediatric intensive care units with a major cause of morbidity and mortality among this age group. The aim of the study is to determine the prevalence and risk factors predisposing...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezk, Ahmed R., Bawady, Somaia Abdelhammed, Omar, Nashwa Naguib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557963/
http://dx.doi.org/10.1186/s43054-021-00071-1
_version_ 1784592463947628544
author Rezk, Ahmed R.
Bawady, Somaia Abdelhammed
Omar, Nashwa Naguib
author_facet Rezk, Ahmed R.
Bawady, Somaia Abdelhammed
Omar, Nashwa Naguib
author_sort Rezk, Ahmed R.
collection PubMed
description BACKGROUND: Healthcare-associated infections (HCAI) are a worldwide threat in intensive care units particularly in the pediatric intensive care units with a major cause of morbidity and mortality among this age group. The aim of the study is to determine the prevalence and risk factors predisposing to multidrug-resistant organisms (MDROs) infections among pediatric intensive care unit (PICU) patients at Ain Shams Pediatric University Hospitals as well as determining mortality and morbidity rates along with the length of stay at PICU. RESULTS: Culture results revealed that of the 282 patients evaluated, only 26 (9.2%) were MDROs (half of the affected patients had Acinetobacter species (50%) and the rest of them were free, 256 (90.8%). Our study revealed that the majority of MDROs were isolated from sputum in more than half of the patients 19/32 (59.3%) followed by whole blood in 10/32 (31.2%) and urine in 3/32 (9.4%). Pulmonary system was the most common affected site and was mainly colonized by MDR Acinetobacter (71.4%) followed by MDR Klebsiella (41.6%). Regarding MDR risk factors in our PICU, multivariate logistic regression analyses showed significant relationship between MDROs and age under 1 year (odds ratio [OR] 2.4554; 95% confidence interval [95% CI] (1.072–5.625); p = 0.043) and underlying pulmonary disease (OR 2.417; 95% CI (1.014–5.761); p = 0.592). A statistically significant higher mortality was detected in patients colonized with MDROs 9/26 (34.6%) versus MDROs non-colonized patients 32/256 (12.5%) [P=0.002]. Moreover, MDROs infection has negative significant risk with discharged patients ([OR] 0.269; [95% CI] (0.111–0.656); p = 0.002). Additionally, patients infected with MDROs did have significantly greater PICU stay than those non-infected [median (IQR), 16.5 (10.7–22), 5 (4–8), P=0.00] and have longer ventilation [median (IQR), 15.5 (10–18), 3 (2–10), P=0.00]. CONCLUSION: Prevalence of MDROs (9.2%) was low among PICU cases at Ain Shams University Hospitals. Most common MDROs were Acinetobacter and Klebsiella followed by pseudomonas species. The frequency of gram-negative organisms is much more common than gram-positive organisms. An increasing rate of antimicrobial resistance with increasing mortality and morbidity among PICU patients is observed worldwide; even for new categories, so, strict infection control programs should be implemented.
format Online
Article
Text
id pubmed-8557963
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85579632021-11-01 Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care Rezk, Ahmed R. Bawady, Somaia Abdelhammed Omar, Nashwa Naguib Egypt Pediatric Association Gaz Research BACKGROUND: Healthcare-associated infections (HCAI) are a worldwide threat in intensive care units particularly in the pediatric intensive care units with a major cause of morbidity and mortality among this age group. The aim of the study is to determine the prevalence and risk factors predisposing to multidrug-resistant organisms (MDROs) infections among pediatric intensive care unit (PICU) patients at Ain Shams Pediatric University Hospitals as well as determining mortality and morbidity rates along with the length of stay at PICU. RESULTS: Culture results revealed that of the 282 patients evaluated, only 26 (9.2%) were MDROs (half of the affected patients had Acinetobacter species (50%) and the rest of them were free, 256 (90.8%). Our study revealed that the majority of MDROs were isolated from sputum in more than half of the patients 19/32 (59.3%) followed by whole blood in 10/32 (31.2%) and urine in 3/32 (9.4%). Pulmonary system was the most common affected site and was mainly colonized by MDR Acinetobacter (71.4%) followed by MDR Klebsiella (41.6%). Regarding MDR risk factors in our PICU, multivariate logistic regression analyses showed significant relationship between MDROs and age under 1 year (odds ratio [OR] 2.4554; 95% confidence interval [95% CI] (1.072–5.625); p = 0.043) and underlying pulmonary disease (OR 2.417; 95% CI (1.014–5.761); p = 0.592). A statistically significant higher mortality was detected in patients colonized with MDROs 9/26 (34.6%) versus MDROs non-colonized patients 32/256 (12.5%) [P=0.002]. Moreover, MDROs infection has negative significant risk with discharged patients ([OR] 0.269; [95% CI] (0.111–0.656); p = 0.002). Additionally, patients infected with MDROs did have significantly greater PICU stay than those non-infected [median (IQR), 16.5 (10.7–22), 5 (4–8), P=0.00] and have longer ventilation [median (IQR), 15.5 (10–18), 3 (2–10), P=0.00]. CONCLUSION: Prevalence of MDROs (9.2%) was low among PICU cases at Ain Shams University Hospitals. Most common MDROs were Acinetobacter and Klebsiella followed by pseudomonas species. The frequency of gram-negative organisms is much more common than gram-positive organisms. An increasing rate of antimicrobial resistance with increasing mortality and morbidity among PICU patients is observed worldwide; even for new categories, so, strict infection control programs should be implemented. Springer Berlin Heidelberg 2021-11-01 2021 /pmc/articles/PMC8557963/ http://dx.doi.org/10.1186/s43054-021-00071-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Rezk, Ahmed R.
Bawady, Somaia Abdelhammed
Omar, Nashwa Naguib
Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
title Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
title_full Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
title_fullStr Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
title_full_unstemmed Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
title_short Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
title_sort incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557963/
http://dx.doi.org/10.1186/s43054-021-00071-1
work_keys_str_mv AT rezkahmedr incidenceofemergingmultidrugresistantorganismsanditsimpactontheoutcomeinthepediatricintensivecare
AT bawadysomaiaabdelhammed incidenceofemergingmultidrugresistantorganismsanditsimpactontheoutcomeinthepediatricintensivecare
AT omarnashwanaguib incidenceofemergingmultidrugresistantorganismsanditsimpactontheoutcomeinthepediatricintensivecare